Teradyne (TER)

Investment Review After Q1 FY2026 Earnings (stock price as of 2026.04.29)

TL;DR

Teradyne is the #2 semiconductor automated test equipment (ATE) maker, with leadership in SoC, memory, and system-level test, plus a robotics segment. Q1 FY2026 was a record quarter: revenue $1.282B (+87% YoY), non-GAAP EPS $2.56 (+241%), gross margin 60.9%, operating margin 37.5% — AI now drives ~70% of revenue. The stock is at $319 with P/E(ttm) of 45x on TTM operating profit of $1,036M; main risk is Q2 OM compression to 31% (from 37% Q1) plus revenue lumpiness from VIP customer concentration as AI demand drives "peaks and valleys superimposed over a long-term strong growth trend."

Summary

Finding	Assessment
5-Year Stock Return	+161% ($122 → $319). Vastly outpaced TTM OP growth of only +13% over 5 years; almost the entire return came from P/E expansion (29x → 45x) as the AI test inflection priced in.
Business Model	#2 semiconductor ATE maker (with Advantest); ~50% share of SoC test. Also runs Memory test, IST/SLT, Product test, and Robotics (Universal Robots). Wafer-to-AI-data-center coverage. HQ North Reading, MA.
Competitive Moat	NARROW. Duopoly with Advantest (~85% combined SoC share), 12-18 month qualification cycles, broad wafer-to-data-center portfolio. But ATE is cyclical, customer-concentrated, and share moves with each technology transition.
Past 5-YR Drivers	AI compute went from rounding error to ~70% of revenue in 2 years. Compute = 75% of SoC. Memory test (HBM/DRAM) ramped sharply. Robotics turning around (4 quarters of sequential growth, 15% AI mix).
Recent Stock Move	Stock currently $319, vs. $90 (Jun 2025). Driven by AI test demand explosion, record Q1 2026 results ($1.282B revenue, +87% YoY), and a 3-wave AI thesis pulling forward the target model.
Revenue Trend	ACCELERATING. $3.2B FY2025 (+13% YoY). Q1 2026 record $1.282B (+87% YoY). Q2 guide $1.15-$1.25B (+89% YoY at high end). FY2026 target $6B revenue at 55-60% 1H weighting.
Margin Trend	COMPRESSING. OM% 37% Q1 → 31% Q2 2026E (-6pp), driven by mix normalization, one-time benefit roll-off, and the Multi-Lane JV / Test Insight integration drag. GM peaked at 60.9% (Q1), Q2 guided 58-59%. Target model: 30-34% OP, 59-61% GM, EPS $9.50-$11.
TTM OP Trajectory	DECELERATING (off a high base). TTM OP $1,036M Q1 (+46% QoQ); Q2 2026E TTM OP $1,327M (+28% QoQ) — growth still huge but pace is slowing as Q2 OM compresses to 31%. Five-year TTM OP +13%.
Key Opportunities	Merchant GPU dual-source share ramping (low double-digit 2026 → 30-70% midterm). Silicon photonics/CPO TAM $300-700M. Multi-Lane JV + Test Insight extend wafer-to-data-center portfolio.
Key Risks	Lumpy revenue from VIP customer concentration (3 >10% customers); short visibility (~1 quarter beyond current). At 45x P/E, no margin for misses. AI wave transitions (general-purpose → inference) add timing risk.
Catalysts	Q2 2026 print ($1.15-$1.25B guide, 30-32% OP rate). Merchant GPU production ramp from Q2 onward. Multi-Lane Test JV + Test Insight closed Apr 2026 (~$165M cash). Silicon photonics ramp visibility through 2027.
P/E(ttm) Valuation	At 45x on Q2 2026E TTM OP of $1,327M, TER is priced for the target model. On midpoint EPS $10.25, forward multiple is ~31x — reasonable if achieved. P/E peaked at 54x in Q1 2026; now starting to grow into the multiple as TTM EPS expands.

Q1 FY2026 Key Data

Revenue $1.282B (record, +87% YoY), EPS $2.56 (+241%). GM 60.9%, OM 37.5% — all-time records. AI = ~70% of revenue (up from 60% in Q4 2025).
SemiTest $1.1B (+100% YoY): SoC $882M (compute 75%), Memory $203M (HBM/DRAM strong), IST $27M. Robotics $91M (4th seq growth qtr). First merchant GPU production orders.
Q2 guide $1.15-$1.25B, EPS $1.86-$2.15, GM 58-59%. FY2026 target: $6B rev, $9.50-$11 EPS, 55-60% 1H weighted (vs. prior 60% point estimate).

Key Takeaways from Earnings Call

Wafer-to-AI-data-center strategy delivering across all 3 businesses. AI = 70% of revenue. Three-wave thesis: general-purpose buildout → inference silicon → edge/physical AI. New products: Photon 100 (CPO test) + Omnyx (AI server boards).
First merchant GPU production orders in Q1 — biggest qualifying project done. Fast-follower phase next; expects "low double-digit" share in 2026, dual-source 30-70% over midterm. ~$50M GPU revenue line-of-sight FY2026.
Margin variability is real (60.9% Q1 → 58-59% Q2 mid). Half is one-time benefits, half normalization. Full-year ~59.7% (low end of 59-61% target). M&A continues — Multi-Lane Test JV + Test Insight closed in April for ~$165M.

Key Segments and Revenue Mix (FY2025)

Segment	Revenue	% of Total	Key Details
Semiconductor Test	$2,524M	79%	SoC test (compute, mobile, auto/industrial), Memory (HBM, DRAM), IST (SLT, HDD); +19% YoY
Product Test	$358M	11%	Circuit board test, defense & aerospace, wireless test, Quantifi Photonics (PIC test); +8% YoY
Robotics	$308M	10%	Universal Robots (cobots), AMRs; pivoting to e-commerce, logistics, physical AI applications

Business Model

SUPPLIERS

Semiconductor components
Precision electromechanics
Electronic assemblies & PCBs
IP & EDA tool licenses

Components / Materials →

TERADYNE

SoC & Memory ATE systems
System-level test (SLT) & HDD test
Production board & photonics test
Collaborative robots & AMRs
$3.2B Revenue FY2025

Test Systems / Robots → $ Revenue

CUSTOMERS

AI chip designers (custom VIPs)
Hyperscalers & foundries
IDMs (Samsung, Micron, TI)
OSATs (ASE, Amkor)
Manufacturing & logistics cos

Moat Assessment: NARROW

Duopoly market structure with Advantest in SoC test (~85% combined share). Long qualification cycles (12-18 months), deep co-design with chip makers, and high switching costs once a tester is qualified create real barriers to entry. But share between Teradyne and Advantest can swing meaningfully on technology transitions (e.g., HBM, GPU dual-source).
Broad wafer-to-data-center test coverage creates cross-sell advantage hyperscalers want. SoC test, memory test, IST/SLT, production board test (Omnyx), photonics (Photon 100, Quantifi), robotics, and high-speed I/O (Multi-Lane JV). No competitor matches this end-to-end footprint, and AI hyperscalers value supply resilience from a single vendor.
Cyclicality and customer concentration cap moat durability. Two specifying customers and one purchasing customer all >10% of revenue. Greg explicitly described the business as "lumpy growth" with peaks and valleys overlaid on the long-term trend. ASIC/VIP socket timing can move revenue across quarters or years.

Stock vs. Earnings — 5-Year Performance

Stock currently $319, vs. $122 (Q1 2021). Teradyne’s stock has more than doubled over five years (+161%), but the path was cyclical: a peak around $168 in mid-2021, a trough at $83 in Q1 2025, then a 3.8x rally to $319 by Q2 2026 as the AI test supercycle inflected.
TTM operating profit moved from $916M (Q1 2021) to $1,036M (Q1 2026), only +13% over five years. The AI inflection just hit: TTM OP languished in the $477M-$710M range from 2022-Q4 2025 and only crossed back above $1B this quarter. Q2 2026 guidance implies TTM OP of ~$1.4B — the real earnings re-rating is still in front of TER, not behind it.
P/E(ttm) expanded from 29x to a 54x peak in Q1 2026, now 45x as projected TTM EPS grows. With TTM OP only +13% in five years, virtually all of the +160% stock return came from multiple expansion. The market is paying ahead for the target model ($6B revenue, $9.50-$11 EPS) rather than current earnings.

Past 5-Year Key Drivers

AI compute test demand has gone from rounding error to ~70% of total revenue in roughly two years. Compute is now 75% of SoC product revenue (vs. mobile-dominant historically). AI drove ~60% of Q4 2025 and ~70% of Q1 2026 revenue. This is a structural mix shift, not a cyclical one — SoC TAM was record in 2025 and continues to grow.
Memory and IST share gains expanding the addressable market beyond the duopoly base. Memory test ramped on HBM/DRAM (Magnum 7 platform fully ramped); flash test demand starting from SSD. IST revenue $27M Q1, with HDD strength expected H2 2026 (20%+ exabyte growth driving longer test times) and continuing into 2027. Low single-digit memory share gains expected for the year.
Margin recovery from a deep cyclical trough — OM% went from 14% (Q1 2024) to 37% (Q1 2026). Five-year TTM OP was nearly flat ($916M to $1,036M) because volume and mix collapsed in 2022-2024. The recovery is now compounding with mix (compute) and operating leverage (60.9% GM, OpEx ~21% of sales) all hitting at once.

Quarterly Key Metrics

USD	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26E
Quarter End	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Stock ($)	113	148	134	126	83	90	138	194	296	319
Stock QoQ	+8%	+31%	-9%	-6%	-34%	+9%	+53%	+41%	+53%	+8%
Rev YoY	-3%	+7%	+5%	+12%	+14%	-11%	+4%	+44%	+87%	+89%
OM%	14%	14%	22%	21%	22%	14%	21%	28%	37%	31%
R40 (RevYoY+OM%)	11%	20%	27%	33%	36%	4%	25%	72%	124%	120%
TTM OP ($M)	529	477	485	508	572	565	561	710	1,036	1,327
TTM OP QoQ	-2%	-10%	+2%	+5%	+12%	-1%	-1%	+26%	+46%	+28%
FCF/OP	78%	100%	93%	93%	107%	101%	82%	64%	53%	58%
Debt/EBITDA	0.1x	0.1x	0.1x	0.1x	0.1x	0.1x	0.4x	0.3x	0.0x	0.0x
P/E(ttm)	41x	53x	46x	41x	24x	29x	46x	52x	54x	45x

Recent Stock Performance & Drivers

Stock currently $319, vs. $90 (Jun 2025). The stock more than tripled in three quarters as the AI compute and memory test cycle inflected, then beat Q1 with records on revenue, EPS, GM, and OM.
P/E(ttm) at 45x on Q2 2026E projected TTM OP of $1,327M — multiple is starting to grow into earnings. Q2 guide is flat-to-slightly-down. On target model EPS midpoint $10.25, forward multiple is ~31x — more reasonable but ahead of trough.
Revenue mix transformed: compute = 75% of SoC, AI = ~70% of total. Q1 was ~$200M above the prior all-time high (Q2 2021 mobile peak). Auto/industrial is now data-center-driven (46% of A&I in Q1 came from data center power).

Opportunities

Merchant GPU share ramping from low single digits toward 30-70% dual-source split midterm. First production orders shipped Q1; ~$50M FY2026 line-of-sight. Fast-follower phase begins; custom ASIC dual-source contests timed for 2027.
Silicon photonics / Co-Packaged Optics is a $300-700M midterm TAM expansion. ~$100M expected this year, balanced share with Advantest. Scale-out networking ramps 2027; scale-up 2028-2029. Photon 100 brings SiPhO testing from lab to fab.
Multi-Lane Test JV (Apr 8) + Test Insight (Apr 16) extend the wafer-to-data-center portfolio. Multi-Lane targets high-speed I/O. Test Insight enables a "virtual test environment" reducing TTM for AI devices — a key fast-follower enabler.

Challenges

Customer concentration and VIP lumpiness limit forecast confidence. Two specifying + one purchasing customer all >10% of revenue. 1H weighting widened to 55-60% (from 60% point) to absorb timing slips and AI data center buildout hiccups.
Gross margin variability is real — 240bps step-down from Q1 (60.9%) to Q2 mid (58.5%). About half is one-time benefits rolling off, half normalization. Full-year ~59.7%, low end of 59-61% target. Up to 400bps swings within a year are expected.
Visibility remains short — only "another quarter out" beyond current. Tester lead times (~12-16 weeks) mean customers don't commit until wafer capacity is ready. At 45x P/E, any miss or weak H2 commentary could trigger sharp de-rating.

Next 12 Months

Q2 2026 guide $1.15-$1.25B (+84% YoY at midpoint), EPS $1.86-$2.15, OP rate 30-32%. A beat extends the AI test surge thesis; in-line/below reinforces H2 lumpiness fears. Memory more 2H-weighted; VIP compute more 1H-weighted.
FY2026 target: $6B revenue, $9.50-$11 EPS, 55-60% revenue in 1H. Hitting midpoint requires ~$2.4-$2.7B in 2H. Networking, memory (HBM/DRAM), and IST (HDD) all expected to step up in 2H; VIP compute steps down.
Multiple expansion is fully priced — from here, earnings beats must drive returns, not re-rating. P/E peaked at 54x in Q1 2026 (range 16x-54x); now 45x as forward TTM EPS catches up. Operating leverage on rising volume is the key swing.

Next 12-24 Months

Three AI waves stacking: general-purpose buildout (current) + inference-at-scale silicon (2026+) + edge/physical AI (later). Each wave adds test demand without prior wave slowing. Inference silicon is the swing factor for late 2026/2027.
GPU and ASIC dual-source share gains are the biggest revenue lever beyond 2026. Path from "low double-digit" 2026 share to 30-70% midterm takes 2-3 years. Tester-agnostic development (Test Insight) levels the field as incumbency erodes.
Silicon photonics/CPO TAM scaling from ~$100M in 2026 to $300-700M midterm. 2027 ramp = scale-out networking; scale-up (2028-2029) = higher volume. Test efficiency expected to improve ~10x, so growth depends on insertion mix not linear extrapolation.

Core Metrics Scorecard

	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26E
Quarter End	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
R40 > 40%	✅	✅																✅	✅	✅
R40 accelerate					✅			✅	✅	✅		✅	✅	✅	✅		✅	✅	✅
TTM OP QoQ > 10%	✅														✅			✅	✅	✅
TTM OP QoQ accelerate	✅				✅	✅		✅	✅		✅		✅	✅	✅		✅	✅	✅
TTM FCF/OP > 60%	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅
Debt/EBITDA < 3.5	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅	✅
Total passes	5	3	2	2	4	3	2	4	4	3	3	3	4	4	5	2	4	6	6	4
Stock QoQ	-19%	+50%	-28%	-24%	-16%	+14%	+25%	+4%	-10%	+4%	+8%	+31%	-9%	-6%	-34%	+9%	+53%	+41%	+53%	+8%
P/E(ttm)	21x	29x	21x	18x	16x	19x	27x	31x	31x	36x	41x	53x	46x	41x	24x	29x	46x	52x	54x	45x

Two 6-pass quarters (Q4 2025, Q1 2026) drove the stock’s 3.8x rally from $83 to $319; Q2 2026E drops to 4 passes as R40 decelerates and the margin cut hits. When R40 >40%, TTM OP QoQ >10%, and both metrics are accelerating, TER inflects violently higher. The 2-pass quarters (Q1 2022, Q2 2022, Q1 2023, Q2 2025) preceded the steepest declines.
FCF/OP and Debt/EBITDA have been perfect passes for 20 consecutive quarters — the financial floor. Near-zero net debt (Debt/EBITDA dropped to 0.0x in Q1 2026 as cash exceeded debt) and consistent cash conversion mean balance sheet never constrains the stock. Valuation is purely growth-driven.
P/E(ttm) range of 16x-54x reveals extreme cyclical valuation swings tied to the ATE/AI cycle. Trough multiples (16-19x) hit during the 2022 mobile collapse; peak 54x in Q1 2026 at the AI test inflection. Currently 45x as the forward TTM EPS grows — a first sign that "growth into" the multiple may be starting.

Chart: R40 vs Stock Price (Since 2020)

Chart: Scorecard Total Passes vs Stock Price (Since 2020)

Source: SEC EDGAR annual and quarterly filings, company earnings conference calls and presentations.

Disclaimer: This report is for educational purposes only. NO investment advice.